Affy Pharma Private Limited, a active private limited company, was established on 17 August 1990 in Shahdara, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232DL1990PTC425092. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.50 M.
It upholds a compliant status. Employing 13 professional, Its leadership includes Sangeeta Billa (Director), Arvind Billa (Director), Aditya Billa (Director). Past directors included Piare Lal Billa. It holds ₹4.93 Cr open charges and ₹26.01 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at N 101 Anupam Apartments, East Arjun Nagar, Shahdara, Delhi, 110032.
U24232DL1990PTC425092
425092
17 August 1990
₹1.50 M
₹1.50 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Affy Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sangeeta Billa | Director | 28 Oct 2001 | Current |
| Arvind Billa | Director | 17 Aug 1990 | Current |
| Aditya Billa | Director | 01 Jul 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Jul 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Affy Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 52.32% decrease. The company also saw a substantial fall in profitability, with a 56.2% decrease in profit. The company's net worth moved up by a moderate rise of 0.84%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Affy Pharma had a public holding of 2.97%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹49,285,136.00
₹260,107,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Jul 2016 | Citi Bank N.A. | ₹0.24 M | Open |
| 28 Jan 2016 | Hdfc Bank Limited | ₹3.00 Cr | Open |
| 21 Dec 2010 | District Industries Centre S.W.C.A. Baddi (H.P.) | ₹1.90 Cr | Open |
| 24 May 2013 | Citibank N.A | ₹9.78 Cr | Satisfied |
| 20 Mar 2013 | Citibank N.A | ₹2.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Affy Pharma has a workforce of 13 employees as of Aug 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Affy Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Affy Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Affy Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Affy Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
Progress on A charge with Hdfc Bank Limited of Rs. 30.00 M registered on 28 Jan 2016 with Charge ID 10626682 was modified on 17 Nov 2022. was documented.
The activity A charge registered on 15 Mar 2010 via Charge ID 10214171 with The Nainital Bank Limited was fully satisfied on 14 Oct 2022. was completed.
A charge registered on 09 Mar 2010 via Charge ID 10214168 with The Nainital Bank Limited was fully satisfied on 14 Oct 2022. was recorded as a recent event.
A charge registered on 30 Oct 2009 via Charge ID 10190556 with The Nainital Bank Limited was fully satisfied on 14 Oct 2022. was recorded as a recent event.
The CIN of Affy Pharma Private Limited is U24232DL1990PTC425092.
Affy Pharma Private Limited is headquartered at N 101 Anupam Apartments, East Arjun Nagar, Shahdara, Delhi, 110032.
Affy Pharma Private Limited was incorporated on 17 August 1990.
The current directors of Affy Pharma Private Limited are
The primary industry of Affy Pharma Private Limited is Manufacturing.
Affy Pharma Private Limited is unlisted.
The authorized capital of Affy Pharma Private Limited is ₹1.50 M, and the paid-up capital is ₹1.50 M.
The compliance status of Affy Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX